Glycan News and Research

RSS

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

From Rapid Novor Inc 23 Aug 2023

Microbiome-directed foods boost child nutrition

Researchers reconstructed gut bacterial genomes.

21 Aug 2023

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

A hybrid approach involving a combination of conventional discovery and antibody repurposing to combat COVID-19.

21 Aug 2023

Glycans and GBPs: How their interplay shapes immunity in infection and autoimmune diseases

Researchers discuss the regulatory roles of glycans and glycan-binding proteins in modulating immune responses.

21 Aug 2023

AI and infection control: preventing infectious disease outbreaks and pandemics

Researchers discussed the role of artificial intelligence (AI) in preventing outbreaks of infectious diseases and future pandemics.

19 Jul 2023

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Researchers evaluated the association between blood group A and SARS-CoV-2 infections.

29 Jun 2023

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses.

19 May 2023

SARS-CoV-2 variants show altered glycan processing

Researchers examine spike-protein trimers from SARS-CoV-2 variants to compare the N (asparagine)-glycan landscape.

15 May 2023

Study findings could be harnessed to engineer new botulinum neurotoxin E variants

A team of researchers from the University of California, Irvine, have revealed the first crystal structures of the receptor-binding domain of botulinum neurotoxin E (BoNT/E) in complex with its human neuronal receptors, synaptic vesicle glycoprotein 2A (SV2A).

27 Apr 2023

Researchers identify regions of the viral envelope of simian foamy viruses targeted by neutralizing antibodies

A recent study characterized epitopes recognized by neutralizing antibodies from individuals infected with simian foamy virus.

26 Apr 2023

Revolutionizing Glycobiology: A Mass Spectrometrist's Perspective

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Professor Albert Heck and gained a mass spectrometrist's perspective on the field of glycobiology.

From Pittcon 24 Apr 2023

Ecological and evolutionary implications of the sharing of metabolites between different microbes in the gut microbiome

The researchers provide important insights into the cross-feeding mechanisms of nutrients in the gut microbiome and their impacts on host health.

18 Apr 2023

Blood levels of glycans can predict the risk of Alzheimer's disease

Early diagnosis and treatment of Alzheimer's disease requires reliable and cost-effective screening methods.

12 Apr 2023

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).

30 Jan 2023

New research draws attention to the effects of deep meditation on gut health

Researchers investigated the effects of long-term traditional Tibetan Buddhist meditation on the gut microbiome's structural characteristics. Additionally, they screened microbes in the gut microbiota for insights into their biochemical indices and functionality.

19 Jan 2023

Glycan News and Research

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Microbiome-directed foods boost child nutrition

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

Glycans and GBPs: How their interplay shapes immunity in infection and autoimmune diseases

AI and infection control: preventing infectious disease outbreaks and pandemics

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

SARS-CoV-2 variants show altered glycan processing

Study findings could be harnessed to engineer new botulinum neurotoxin E variants

Researchers identify regions of the viral envelope of simian foamy viruses targeted by neutralizing antibodies

Revolutionizing Glycobiology: A Mass Spectrometrist's Perspective

Ecological and evolutionary implications of the sharing of metabolites between different microbes in the gut microbiome

Blood levels of glycans can predict the risk of Alzheimer's disease

Structure and function of the first FDA-approved treatment for Ebola virus discovered

New research draws attention to the effects of deep meditation on gut health

The diverse mechanisms by which galectins can regulate adaptive and innate immune responses

Scientists identify molecules in mucus that can block cholera infection

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Glycan signatures in rheumatic diseases and their associated functional implications

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News